Delayed-Release Oral Mesalamine 4.8 g/day (800 mg tablets) Compared with 2.4 g/day (400 mg tablets) for the Treatment of Mildly to Moderately Active Ulcerative Colitis: The ASCEND I Trial
Hanauer, Stephen B, Sandborn, William J, Dallaire, Christian, Archambault, André, Yacyshyn, Bruce, Yeh, Chyon, Smith-Hall, NancyVolume:
21
Year:
2007
Journal:
Canadian Journal of Gastroenterology
DOI:
10.1155/2007/862917
File:
PDF, 1.32 MB
2007